share_log

平安好醫生：聯合公告 瑞銀為及代表要約人作出可能的強制性無條件現金要約(I)以收購所有已發行股份及根據以股代息計劃將予發行之股份（要約人及其一致行動人士已擁有及根據以股代息計劃將向其發行的部分除外）及(II)以註銷所有尚未行使購股權

PA GOODDOCTOR: JOINT ANNOUNCEMENT POSSIBLE MANDATORY UNCONDITIONAL CASH OFFERS BY UBS FOR AND ON BEHALF OF THE OFFEROR (I) TO ACQUIRE ALL ISSUED SHARES AND SHARES TO BE ISSUED UNDER THE SCRIP DIVIDEND SCHEME (OTHER THAN THOSE ALREADY OWNED BY AND TO BE ISSUED UNDER THE S

HKEX ·  Jan 7 21:22

Summary by Moomoo AI

平安好醫生控股股東安鑫有限公司擬以每股6.12港元的價格強制收購少數股東持有的股份。此次收購源於公司派發特別股息後,安鑫持股比例將由39.41%增至52.74%,觸發強制要約收購。收購價較公告前一日收市價6.30港元折讓2.86%,較過去5個交易日平均收市價折讓1.58%。安鑫表示無意將公司私有化,並承諾維持公司在港交所的上市地位。此次要約須待港交所批准新股上市後方可作實。公司已成立獨立董事委員會,並委任八方金融為獨立財務顧問,就要約是否公平合理及是否接納向獨立股東及購股權持有人提供意見。綜合要約文件預計將於先決條件達成後7日內寄發。
平安好醫生控股股東安鑫有限公司擬以每股6.12港元的價格強制收購少數股東持有的股份。此次收購源於公司派發特別股息後,安鑫持股比例將由39.41%增至52.74%,觸發強制要約收購。收購價較公告前一日收市價6.30港元折讓2.86%,較過去5個交易日平均收市價折讓1.58%。安鑫表示無意將公司私有化,並承諾維持公司在港交所的上市地位。此次要約須待港交所批准新股上市後方可作實。公司已成立獨立董事委員會,並委任八方金融為獨立財務顧問,就要約是否公平合理及是否接納向獨立股東及購股權持有人提供意見。綜合要約文件預計將於先決條件達成後7日內寄發。
PA GOODDOCTOR's controlling Shareholder, Anxin Co., Ltd., plans to compulsorily acquire the shares held by minority Shareholders at a price of HKD 6.12 per share. This acquisition stems from the company's distribution of a special dividend, after which Anxin's shareholding ratio will increase from 39.41% to 52.74%, triggering a mandatory offer to acquire. The acquisition price represents a discount of 2.86% compared to the closing price of HKD 6.30 per share on the day before the announcement, and a discount of 1.58% compared to the average closing price over the past five trading days. Anxin has stated that it has no intention to privatize the company and has committed to maintaining the company's listing status on the Hong Kong Stock Exchange. This...Show More
PA GOODDOCTOR's controlling Shareholder, Anxin Co., Ltd., plans to compulsorily acquire the shares held by minority Shareholders at a price of HKD 6.12 per share. This acquisition stems from the company's distribution of a special dividend, after which Anxin's shareholding ratio will increase from 39.41% to 52.74%, triggering a mandatory offer to acquire. The acquisition price represents a discount of 2.86% compared to the closing price of HKD 6.30 per share on the day before the announcement, and a discount of 1.58% compared to the average closing price over the past five trading days. Anxin has stated that it has no intention to privatize the company and has committed to maintaining the company's listing status on the Hong Kong Stock Exchange. This offer is subject to approval by the Hong Kong Stock Exchange after the listing of the new shares. The company has established an independent Director committee and appointed Bafang Financial as an independent financial advisor to provide opinions on whether the offer is fair and reasonable and whether it should be accepted by independent Shareholders and warrant holders. The composite offer document is expected to be sent within 7 days after the fulfillment of the preconditions.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated